Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹9,675 Cr
Revenue (TTM)
₹1,566 Cr
Net Profit (TTM)
₹168 Cr
ROE
12.1 %
ROCE
17.6 %
P/E Ratio
57.5
P/B Ratio
6.6
Industry P/E
42.28
EV/EBITDA
25.4
Div. Yield
0 %
Debt to Equity
0
Book Value
₹284.5
EPS
₹33.7
Face value
2
Shares outstanding
51,831,942
CFO
₹1,844.38 Cr
EBITDA
₹2,431.94 Cr
Net Profit
₹1,367.59 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Metropolis Health
| -3.2 | -3.2 | -1.2 | 16.4 | 13.6 | 0.0 | -- |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Metropolis Health
| -6.2 | 24.0 | 26.4 | -61.4 | 70.8 | 36.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Metropolis Health
|
1,867.9 | 9,674.7 | 1,566.5 | 169.5 | 14.8 | 12.7 | 57.5 | 6.6 |
| 141.4 | 80.6 | 49.6 | 5.3 | 11.7 | 13.8 | 15.3 | 2.2 | |
| 1,346.9 | 22,583.1 | 2,662.8 | 533.1 | 22.9 | 24.1 | 42.7 | 8.8 | |
| 672.0 | 26,925.4 | 3,626.9 | 315.0 | 15.0 | 13.3 | 89.5 | 11.6 | |
| 605.1 | 1,960.4 | 766.3 | 80.5 | 15.7 | 8.9 | 24.4 | 2.1 | |
| 271.6 | 367.9 | 166.7 | 7.2 | 3.9 | 3.9 | 39 | 1.4 | |
| 285.6 | 929.3 | 1,231.3 | 29.1 | -4.7 | 4 | 35.7 | 1.4 | |
| 263.9 | 1,360.9 | 294.1 | 32.4 | 17.4 | 15.1 | 40.9 | 5.7 | |
| 372.7 | 5,934.5 | 792.3 | 135.5 | 23.5 | 26.4 | 43.1 | 8.9 | |
| 938.2 | 9,082.5 | 768.1 | 159.9 | 29.2 | 19.3 | 57 | 10.0 |
Sticking with experts during uncertainty
4 min read•By Rajan Gulati
Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology,... as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India. Read more
Incorporated
2000
Chairman
Ameera Shah
Managing Director
--
Group
Metropolis
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Metropolis Healthcare Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Metropolis Healthcare Ltd is ₹1,867.90 (NSE) and ₹1,866.55 (BSE) as of 18-Mar-2026 IST. Metropolis Healthcare Ltd has given a return of 13.64% in the last 3 years.
The P/E ratio of Metropolis Healthcare Ltd is 57.50 times as on 18-Mar-2026, a 36 premium to its peers’ median range of 42.28 times.
The P/B ratio of Metropolis Healthcare Ltd is 6.56 times as on 18-Mar-2026, a 10 discount to its peers’ median range of 7.32 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
55.84
|
6.12
|
|
2024
|
69.19
|
8.13
|
|
2023
|
44.76
|
6.52
|
|
2022
|
48.66
|
11.92
|
|
2021
|
62.57
|
16.41
|
The 52-week high and low of Metropolis Healthcare Ltd are Rs 2,263.00 and Rs 1,315.00 as of 19-Mar-2026.
Metropolis Healthcare Ltd has a market capitalisation of ₹ 9,675 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Metropolis Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹9.90
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.